Anti –Oral Mucositis Drug Granted Breakthrough Status

The FDA has granted Breakthrough Therapy and Fast Track designation to GC4419, for reduction of severe oral mucositis caused by radiation therapy.

Source: CancerNetwork - March 9, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: FDA Approval News Palliative and Supportive Care Source Type: news